NO20024256L - Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet - Google Patents

Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet

Info

Publication number
NO20024256L
NO20024256L NO20024256A NO20024256A NO20024256L NO 20024256 L NO20024256 L NO 20024256L NO 20024256 A NO20024256 A NO 20024256A NO 20024256 A NO20024256 A NO 20024256A NO 20024256 L NO20024256 L NO 20024256L
Authority
NO
Norway
Prior art keywords
preparation
antifungal activity
pyrimidone derivatives
pyrimidone
derivatives
Prior art date
Application number
NO20024256A
Other languages
English (en)
Other versions
NO323314B1 (no
NO20024256D0 (no
Inventor
Javier Bartoli Orpi
Manuel Anguita Lopez
Original Assignee
Uriach & Cia Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cia Sa J filed Critical Uriach & Cia Sa J
Publication of NO20024256L publication Critical patent/NO20024256L/no
Publication of NO20024256D0 publication Critical patent/NO20024256D0/no
Publication of NO323314B1 publication Critical patent/NO323314B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20024256A 2000-03-07 2002-09-06 Fremgangsmate for fremstilling av pyrimidonderivater med antifungal aktivitet NO323314B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000625A ES2159488B1 (es) 2000-03-07 2000-03-07 Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
PCT/ES2001/000081 WO2001066519A2 (es) 2000-03-07 2001-03-05 Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica

Publications (3)

Publication Number Publication Date
NO20024256L true NO20024256L (no) 2002-09-06
NO20024256D0 NO20024256D0 (no) 2002-09-06
NO323314B1 NO323314B1 (no) 2007-03-12

Family

ID=8492714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024256A NO323314B1 (no) 2000-03-07 2002-09-06 Fremgangsmate for fremstilling av pyrimidonderivater med antifungal aktivitet

Country Status (17)

Country Link
US (1) US6653475B2 (no)
EP (1) EP1282084B9 (no)
JP (1) JP4772248B2 (no)
KR (1) KR100735583B1 (no)
AR (1) AR027607A1 (no)
AT (1) ATE250256T1 (no)
AU (1) AU2001237447A1 (no)
BR (1) BRPI0108990B8 (no)
CA (1) CA2402390C (no)
DE (1) DE60100810T2 (no)
DK (1) DK1282084T3 (no)
ES (2) ES2159488B1 (no)
HK (1) HK1052244B (no)
MX (1) MXPA02008556A (no)
NO (1) NO323314B1 (no)
PT (1) PT1282084E (no)
WO (1) WO2001066519A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
WO2003064399A1 (fr) * 2002-01-28 2003-08-07 Ube Industries, Ltd. Procede de production de derive de quinazolin-4-one
US7812045B2 (en) 2005-03-30 2010-10-12 Daewoong Pharmaceutical Co., Ltd. Antifungal triazole derivatives
MX2009001208A (es) * 2006-08-07 2009-04-14 Stiefel Laboratories Compuestos cristalinos antifungicos.
EP2009009A1 (en) * 2007-06-26 2008-12-31 Palau Pharma, S.A. Crystalline antifungal compounds
EP1887004A1 (en) * 2006-08-07 2008-02-13 Palau Pharma, S.A. Crystalline forms of (1R,2R)-7-Chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one
TWI395728B (zh) 2006-12-06 2013-05-11 Du Pont 製備２-胺基-５-氰基苯甲酸衍生物之方法
TWI415827B (zh) 2006-12-21 2013-11-21 Du Pont 製備２-胺基-５-氰基苯甲酸衍生物之方法
WO2009109983A1 (en) 2008-03-03 2009-09-11 National Chemical Laboratory Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof
SE532624C2 (sv) * 2008-06-19 2010-03-09 Andritz Technology And Asset Management Gmbh Kylning av en cellulosamassabana
WO2012123952A1 (en) * 2011-03-15 2012-09-20 Fdc Limited Enantiomers of fluconazole analogues containing thieno-[2,3-d]pyrimidin-4(3h)-one moiety as antifungal agents
CN106588889B (zh) * 2016-11-25 2019-01-22 江苏恒盛药业有限公司 一种伏立康唑的制备方法
CN111018839B (zh) * 2019-12-02 2022-12-23 中国人民解放军第二军医大学 三氮唑醇类衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
TW218017B (no) 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
PT783501E (pt) * 1995-08-02 2001-04-30 Uriach & Cia Sa J Derivados de pirimidona com actividade antifungica

Also Published As

Publication number Publication date
DE60100810T2 (de) 2004-07-01
CA2402390C (en) 2009-09-15
BRPI0108990B8 (pt) 2021-05-25
ES2159488A1 (es) 2001-10-01
AU2001237447A1 (en) 2001-09-17
DK1282084T3 (da) 2004-02-02
US6653475B2 (en) 2003-11-25
ATE250256T1 (de) 2003-10-15
ES2159488B1 (es) 2002-04-16
AR027607A1 (es) 2003-04-02
CA2402390A1 (en) 2001-09-13
EP1282084B1 (en) 2003-09-17
NO323314B1 (no) 2007-03-12
HK1052244B (zh) 2003-12-19
MXPA02008556A (es) 2003-02-24
KR100735583B1 (ko) 2007-07-04
JP4772248B2 (ja) 2011-09-14
JP2004500391A (ja) 2004-01-08
HK1052244A1 (en) 2003-09-05
DE60100810D1 (de) 2003-10-23
BR0108990B1 (pt) 2014-03-25
EP1282084B9 (en) 2005-03-02
EP1282084A2 (en) 2003-02-05
PT1282084E (pt) 2004-02-27
WO2001066519A2 (es) 2001-09-13
KR20020075809A (ko) 2002-10-05
NO20024256D0 (no) 2002-09-06
WO2001066519A3 (es) 2002-01-31
US20030064986A1 (en) 2003-04-03
BR0108990A (pt) 2003-12-30
ES2207605T3 (es) 2004-06-01

Similar Documents

Publication Publication Date Title
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20032827D0 (no) Fremgangsmåte for fremstilling av det anticholinerge middel tiotropiumbromid
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
NO20015017L (no) Fremgangsmate for fremstilling av citalopram
NO20010319D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20024256D0 (no) Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20022956L (no) Fremgangsmate for fremstilling av nitroguanidin
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20021788D0 (no) Fremgangsmåte for fremstilling av ulcerterapeutika
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater
NO20013453D0 (no) Fremgangsmåte for fremstilling av salter av cyanobenzylaminer
NO20022671D0 (no) Fremgangsmåte for fremstilling av tienopyrimidiner
NO20002558D0 (no) FremgangsmÕte for fremstilling av findisperse eksplosivstoffer

Legal Events

Date Code Title Description
MK1K Patent expired